Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / articles / EVAX - Why Is Cancer Immunotherapy Focused Evaxion Biotech Stock Trading Higher Today? | Benzinga

EVAX - Why Is Cancer Immunotherapy Focused Evaxion Biotech Stock Trading Higher Today? | Benzinga

Evaxion Biotech A/S

Evaxion Biotech A/S (NASDAQ: EVAX) collaborated with Afrigen Biologics to develop a prophylactic vaccine based on Evaxion's EDEN-discovered gonorrhea targets.

Evaxion's Chief Scientific Officer, Birgitte Rønø, stated, "This partnership has the potential to address a serious unmet global medical need against the pathogen for which no vaccine currently exists."

Gonorrhea, caused by ...

Full story available on Benzinga.com
Stock Information
Company Name: Evaxion Biotech A/S
Stock Symbol: EVAX
Market: NASDAQ
Website: evaxion-biotech.com
Menu
EVAX EVAX Quote EVAX Short EVAX News EVAX Articles EVAX Message Board
Get EVAX Alerts

News, Short Squeeze, Breakout and More Instantly...